Work

Phase 3 Myasthenia Gravis Inebilizumab Trial (MINT): Efficacy and Safety Results in Patients with Generalized MG (PL5.005)

Year: 2025

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000211217

Authors: Richard J. Nowak, Kimiaki Utsugisawa, Michael Benatar, Emma Ciafaloni, M. Isabel Leite, John Vissing, Fengming Tang, Yanping Wu, Mikhail Rojavin, Nishi Rampal, Sue Cheng, James F. Howard

Institutions: Yale University, General Hanamaki Hospital, University of Miami, University of Rochester, University of Oxford, University of Copenhagen, Amgen (United States), University of North Carolina at Chapel Hill

Language: English

Topic: Myasthenia Gravis and Thymoma

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409226205

FWCI:

Cites:

Cited by:

Related to: 10